Miostatina
DOI:
https://doi.org/10.33233/rbfe.v8i4.3597Abstract
A descoberta da miostatina, uma proteína que limita o desenvolvimento do músculo esquelético, é de grande importância para a minimização da perda de massa muscular magra em indivíduos que possuam patologias em que a distrofia e a atrofia muscular sejam muito grandes. Estudos tentam descobrir como inibir essa proteína e os possíveis efeitos colaterais causados pela mesma. Esta revisão tem como objetivo analisar alguns dos estudos realizados e explanar sobre os pontos mais importantes a serem estudados sobre a miostatina.
Palavras-chave: miostatina, proteína, patologias, músculo esquelético.
References
Rodgers BD, Garikipati DK. Clinical, agricultural, and evolutionary biology of myostatin: A comparative review. Endocrine Reviews 2008;29:513-34
Schuelke M, Wagner KR, Stolz LE, Hübner C, Riebel T, Kömen W et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 2004;350: 2682-8.
Yamada AK. Hipertrofia do músculo esquelético: aspectos fisiológicos, celulares e moleculares. 6ª Mostra Acadêmica UNIMEP [online]. [citado 2009 Jun 13]. DisponÃvel em URL: http://www.unimep.br
Wehling M, Cai B, Tidball JG. Modulation of myostatin expression during modified muscle use. FASEB J 2000;14:103-10.
Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Medical Sciences 2001;98:9306-11.
Artioli GG, Hirata RDC, Lancha Junior AH. Gene therapy, genetic doping and sport: fundaments and implications for the future. Rev Bras Med Esporte 2007;13:317-21.
Carlson CJ, Booth FW, Gordon SE. Skeletal muscle myostatin m-RNA expression is fiber-type specific and increases during hindlimb unloading. Am J Physiol 1999;277:601-6.
Hill JJ, Qiu Y, Hewick RM, Wolfman NM. Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: A novel protein with protease inhibitor and follistatin domains. Mol Endocrinol 2003;17:1144-54.
RÃos R, Fernández-Nocelos S, Carneiro I, Arce VM, Devesa J. Differential response to exogenous and endogenous myostatin in myoblasts suggests that myostatin acts as an autocrine factor in vivo. Endocrinology 2004;145:2795-803.
Hill JJ, Davies MV, Pearson AA, Wang JH, Hewick RM, Wolfman NM et al. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 2002;277: 40735-41.
Tobin JF, Celeste AJ. Myostatin, a negative regulator of muscle mass: implications for muscle degenerative diseases. Curr Opin Pharmacol 2005;5:328-32.
Wolfman NM, McPherron AC, Pappano WN, Davies MV, Song K, Tomkinson KN et al. Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Medical Sciences 2003;100:15842-6.
Bogdanovich S, Perkins KJ, Krag TOB, Whittemore LA, Khurana TS. Myostatin propeptide-mediated amelioration of dystrophic pathophysiology. FASEB J 2005;19:543-9.
Zhu X, Hadhazy M, Wehling M, Tidball JG, McNally EM. Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Lett 2000;474:71-5.
Bogdanovich S, Krag TOB, Barton ER, Morris LD, Whittemore LA, Ahima RS et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature 2002;420: 418-21.
Wagner KR, Liu X, Chang X, Ellen RE. Muscle regeneration in the prolonged absence of myostatin. Medical Sciences 2005;102:2519-24.
Lin J, Arnold HB, Della-Fera LA, Azain MJ, Hartzell DL, Baile CA. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem Biophys Res Commun 2002;291:701-6.
Tay GK, Iaschi SPA, Bellinge RHS, Chong FN, Hui J. The development of sequence-based-typing of myostatin (GDF-8) to identify the double muscling phenotype in the goat. Small Ruminant Res 2004;52:1-12.
Girgenrath S, Song K, Whittemore LA. Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow and fast-type skeletal muscle. Muscle & Nerve 2004;31:34-40.
Taylor WE, Bhasin S, Artaza J, Byhower F, Azam M, Willard DH et al. Myostatin inhibits cell proliferation and protein synthesis in C²C¹² muscle cells. Am J Physiol Endocrinol Metab 2001;280:221-8.
Ma K, Mallidis C, Bahsin S, Mahabadi V, Artaza J, Cadavid NG et al. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab 2003;285:363-71.
Gilson H, Schakman O, Combaret L, Lause P, Grobet L, Attaix D et al. Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy. Endocrinology 2007;148:452-60.
Matsakas A, Diel P. The growth factor myostatin, a key regulator in skeletal muscle growth and homeostasis. Int J Sports Med 2005;26:83-9.
Tsuchida K. The role of myostatin and bone morphogenetic proteins in muscular disorders. Expert Opin Biol Ther 2006;6:147-54.
Engvall E, Wewer UM. The new frontier in muscular dystrophy research: booster genes. FASEB J 2003;17:1579-84.
Downloads
Published
Issue
Section
License
Authors who publish in this journal agree to the following terms: Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License which allows the sharing of work with acknowledgment of authorship and initial publication in this magazine; Authors are authorized to assume additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (eg, publish in an institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal; Authors are allowed and encouraged to publish and distribute their work online (eg, in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase impact and citation of published work (See The Effect of Open Access).
